SEC 13F Intelligence

Saratoga Research & Investment Management / JNJ

Saratoga Research & Investment Management’s Johnson & Johnson Position

Does Saratoga Research & Investment Management own Johnson & Johnson (JNJ)? Yes — 339.4K shares worth $83M (+4.71% of its 13F portfolio) as of Q1 2026, down from 460.2K shares the prior filed quarter.

Position Value
$83M
Q1 2026
Shares
339.4K
% of Portfolio
+4.71%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $28MQ4 ’18Q1 ’19: $30MQ2 ’19: $31MQ3 ’19: $28MQ4 ’19: $32MQ4 ’19Q1 ’20: $42MQ2 ’20: $46MQ3 ’20: $49MQ4 ’20: $55MQ4 ’20Q1 ’21: $63MQ2 ’21: $64MQ3 ’21: $64MQ4 ’21: $69MQ4 ’21Q1 ’22: $71MQ2 ’22: $68MQ3 ’22: $68MQ4 ’22: $71MQ4 ’22Q1 ’23: $68MQ2 ’23: $76MQ3 ’23: $71MQ4 ’23: $68MQ4 ’23Q1 ’24: $70MQ2 ’24: $81MQ3 ’24: $86MQ4 ’24: $75MQ4 ’24Q1 ’25: $84MQ2 ’25: $77MQ3 ’25: $90MQ4 ’25: $95MQ4 ’25Q1 ’26: $83Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026339.4K$83M+4.71%
Q4 2025460.2K$95M+4.99%
Q3 2025485.6K$90M+4.68%
Q2 2025501.4K$77M+4.10%
Q1 2025504.4K$84M+4.42%
Q4 2024520.4K$75M+3.80%
Q3 2024532.4K$86M+3.78%
Q2 2024551.8K$81M+3.67%
Q1 2024439.5K$70M+3.16%
Q4 2023435.1K$68M+3.15%
Q3 2023456.6K$71M+3.47%
Q2 2023458.4K$76M+3.50%
Q1 2023440.4K$68M+3.24%
Q4 2022404.0K$71M+3.53%
Q3 2022416.4K$68M+3.60%
Q2 2022381.0K$68M+3.35%
Q1 2022400.0K$71M+3.09%
Q4 2021401.2K$69M+2.92%
Q3 2021396.6K$64M+2.96%
Q2 2021387.3K$64M+3.01%
Q1 2021384.6K$63M+3.20%
Q4 2020347.4K$55M+2.93%
Q3 2020328.1K$49M+2.93%
Q2 2020330.6K$46M+2.94%
Q1 2020323.4K$42M+2.94%
Q4 2019217.2K$32M+1.90%
Q3 2019217.3K$28M+1.82%
Q2 2019219.6K$31M+1.92%
Q1 2019216.6K$30M+2.07%
Q4 2018216.3K$28M+2.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saratoga Research & Investment Management’s full portfolio or all institutional holders of JNJ.